Education
About Us
Working with TipRanks
Follow Us
SOPHiA GENETICS (SOPH)
NASDAQ:SOPH
SOPH Stock Chart & Stats
$5.02
-$0.07(-2.14%)
At close: 4:00 PM EST
$5.02
-$0.07(-2.14%)
Day’s Range― - ―
52-Week Range$2.58 - $5.70
Previous CloseN/A
Volume4.05K
Average Volume (3M)100.95K
Market Cap
$339.24M
Enterprise Value$321.00M
Total Cash (Recent Filing)$81.61M
Total Debt (Recent Filing)$63.37M
Price to Earnings (P/E)―
Beta1.32
Next Earnings
Mar 03, 2026EPS Estimate
-0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.30
Shares Outstanding67,847,060
10 Day Avg. Volume137,858
30 Day Avg. Volume100,949
Financial Highlights & Ratios
PEG Ratio0.15
Price to Book (P/B)2.09
Price to Sales (P/S)3.10
P/FCF Ratio-3.96
Enterprise Value/Market Cap0.95
Enterprise Value/Revenue4.38
Enterprise Value/Gross Profit6.49
Enterprise Value/Ebitda-5.55
Forecast
1Y Price Target
$7.00Price Target Upside39.44% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Customer Growth And BacklogRecord levels of new customer signings and a growing implementation backlog are poised to convert into higher billed volumes, driving top-line growth as more clients begin paid testing.
Major Strategic ContractA newly signed multi‑year agreement with a large pharmaceutical partner provides a sizable, recurring revenue stream and validates the platform for other enterprise customers.
Pricing Power And Margin ExpansionRising average contract values and an expanding menu of higher‑priced tests are expected to increase average selling prices and improve gross margins as larger deals comprise more revenue.
Bears Say
SOPHiA GENETICS News
SOPH FAQ
What was SOPHiA GENETICS’s price range in the past 12 months?
SOPHiA GENETICS lowest stock price was $2.58 and its highest was $5.70 in the past 12 months.
What is SOPHiA GENETICS’s market cap?
SOPHiA GENETICS’s market cap is $339.24M.
When is SOPHiA GENETICS’s upcoming earnings report date?
SOPHiA GENETICS’s upcoming earnings report date is Mar 03, 2026 which is in 26 days.
How were SOPHiA GENETICS’s earnings last quarter?
SOPHiA GENETICS released its earnings results on Nov 04, 2025. The company reported -$0.3 earnings per share for the quarter, missing the consensus estimate of -$0.23 by -$0.07.
Is SOPHiA GENETICS overvalued?
According to Wall Street analysts SOPHiA GENETICS’s price is currently Undervalued.
Does SOPHiA GENETICS pay dividends?
SOPHiA GENETICS does not currently pay dividends.
What is SOPHiA GENETICS’s EPS estimate?
SOPHiA GENETICS’s EPS estimate is -0.24.
How many shares outstanding does SOPHiA GENETICS have?
SOPHiA GENETICS has 67,847,060 shares outstanding.
What happened to SOPHiA GENETICS’s price movement after its last earnings report?
SOPHiA GENETICS reported an EPS of -$0.3 in its last earnings report, missing expectations of -$0.23. Following the earnings report the stock price went down -6.4%.
Which hedge fund is a major shareholder of SOPHiA GENETICS?
Currently, no hedge funds are holding shares in SOPH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SOPHiA GENETICS Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
21.40%
12-Months-Change
Fundamentals
Return on Equity
-86.09%
Trailing 12-Months
Asset Growth
-1.92%
Trailing 12-Months
Company Description
SOPHiA GENETICS
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
SOPH Company Deck
SOPH Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong performance for SOPHiA GENETICS with significant revenue growth, new customer acquisition, and global partnerships. Despite some challenges such as operating losses, cash burn, and regional softness, the company's innovation and strategic expansions provide a positive outlook.View all SOPH earnings summariesSOPH Stock 12 Month Forecast
Average Price Target
$7.00
▲(39.44% Upside)
Technical Analysis
Schrodinger
―
Zhongchao
―
GeneDx Holdings
―
Definitive Healthcare Corp
―
Omada Health, Inc.
―
Ownership Overview
―
Insiders
1.22% Mutual Funds
3.83% Other Institutional Investors
94.87% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---